Journal article
In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant).
Abstract
SOURCE CITATION: Madhi SA, Baillie V, Cutland CL, et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. N Engl J Med. 2021. [Epub ahead of print.] 33725432.
Authors
Irfan N; Chagla Z
Journal
Annals of Internal Medicine, Vol. 174, No. 5,
Publisher
American College of Physicians
Publication Date
May 2021
DOI
10.7326/acpj202105180-050
ISSN
1056-8751